The Paul Marks Lab

The Paul Marks Lab

The study of agents that selectively target histone deacetylases and cause transformed cell growth arrest, terminal differentiation, apoptosis, and cell death.

Pictured: Paul Marks

Paul A. Marks, MD

Research Focus

Cell biologist Paul Marks focuses on the study of agents that selectively target histone deacetylases and cause transformed cell growth arrest, terminal differentiation, apoptosis, and/or cell death.

Selected Achievements

  • Biotechnology Achievement Award, Dart /NYU (2013)
  • Doctor of Science (hon. Caus.), Columbia University (2000)
  • Gold Medal for Distinguished Academic Accomplishments, Columbia University College of Physicians and Surgeons (1994)
  • President's National Medal of Science (1991)
  • President's Cancer Panel (1976-1979)
Read more
  • Council, National Academy of Sciences (1984-1987)
  • Discovery of SAHA (vorinostat)
  • Identification of HDAC6 specific inhibitor